Several studies have reported significant upregulation of TOP2A mRNA and protein expression in hepatocellular carcinoma (HCC), suggesting that TOP2A is overexpressed in this cancer type and may serve as a potential biomarker for HCC (42). This evidence concerns the gene TOP2A and hepatocellular carcinoma.